RIGI and breast carcinoma: In addition, SEC14L1 affects innate immune processes by negatively regulating RIG-I-mediated antiviral signaling (Li et al., 2013) and is involved in the immune process of some diseases, such as lymphovascular invasion in breast cancer (Sonbul et al., 2018).